Scientific Publications Database
Article Title: Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinomaAuthors: Hu, Liang-Shuo; Weiss, Matthew; Popescu, Irinel; Marques, Hugo P.; Aldrighetti, Luca; Maithel, Shishir K.; Pulitano, Carlo; Bauer, Todd W.; Shen, Feng; Poultsides, George A.; Soubrane, Oliver; Martel, Guillaume; Koerkamp, B. Groot; Itaru, Endo; Pawlik, Timothy M.
Journal: JOURNAL OF SURGICAL ONCOLOGY Volume 119 Issue 1
Date of Publication:2019
Abstract:
Background Microvascular invasion (MiVI) is a histological feature of intrahepatic cholangiocarcinoma (ICC) that may be associated with biological behavior. We sought to investigate the impact of MiVI on long-term survival of patients undergoing curative-intent resection for ICC. Methods A total of 1089 patients undergoing curative-intent resection for ICC were identified. Data on clinicopathological characteristics, disease-free survival (DFS), and overall survival (OS) were compared among patients with no vascular invasion (NoVI), MiVI, and macrovascular invasion (MaVI). Results A total of 249 (22.9%) patients had MiVI, while 149 (13.7%) patients had MaVI (+/- MiVI). MiVI was associated with higher incidence of perineural, biliary and adjacent organ invasion, and satellite lesions (all P < 0.01). On multivariable analysis, MiVI was an independent risk factor of DFS (hazard ratios [HR] 1.5; 95%confidence intervals [CI], 1.3-1.9; P < 0.001), but not OS (HR 1.1; 95%CI, 0.9-1.3; P = 0.379). While MiVI and MaVI patients had similar DFS (median, MiVI 14.0 vs MaVI 12.0 months, HR 0.9; 95%CI, 0.7-1.2; P = 0.377), OS was better among MiVI patients (median, MiVI 39.0 vs MaVI 21.0 months, HR 0.7; 95%CI, 0.5-0.8; P = 0.002). Whereas nodal metastasis, R1 margin, and postoperative morbidity were associated with early death (<= 18 months) among patients with MiVI, only nodal metastasis was associated with late (>18 months) prognosis. Conclusions Roughly 1 out of 5 patients with resected ICC had MiVI. MiVI was associated with advanced tumor characteristics and a higher risk of tumor recurrence.